Spinal meningiomas.

molecular and genetic targets recurrence rate surgical therapy

Journal

Neuro-oncology advances
ISSN: 2632-2498
Titre abrégé: Neurooncol Adv
Pays: England
ID NLM: 101755003

Informations de publication

Date de publication:
May 2023
Historique:
medline: 8 6 2023
pubmed: 8 6 2023
entrez: 8 6 2023
Statut: epublish

Résumé

Spinal meningiomas (SM) are lesions with a mostly favorable oncological and surgical prognosis and a low incidence of tumor recurrence. SM account for approximately 1.2-12.7% of all meningiomas and 25% of all spinal cord tumors. Typically, SM are located in the intradural extramedullary space. SM grow slowly and spread laterally into the subarachnoid space, stretching and sometimes incorporating the surrounding arachnoid but rarely the pia. Standard treatment is surgery with the primary aims of achieving complete tumor resection as well as improving and recovering neurologic function. Radiotherapy may be considered in case of tumor recurrence, for challenging surgical cases, and for patients with higher-grade lesions (World Health Organization grade 2 or 3); however, radiotherapy is mostly used as an adjuvant therapy for SM. New molecular and genetic profiling increases the understanding of SM and may uncover additional treatment options.

Identifiants

pubmed: 37287574
doi: 10.1093/noajnl/vdad013
pii: vdad013
pmc: PMC10243846
doi:

Types de publication

Journal Article

Langues

eng

Pagination

i112-i121

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology.

Références

Lancet Oncol. 2017 May;18(5):682-694
pubmed: 28314689
World Neurosurg. 2022 Aug;164:e852-e860
pubmed: 35605940
J Neurooncol. 2010 Sep;99(3):341-7
pubmed: 20714782
Curr Opin Neurol. 2021 Dec 1;34(6):857-867
pubmed: 34629433
Neurosurgery. 2001 Oct;49(4):838-46
pubmed: 11564244
Neurosurg Clin N Am. 2016 Apr;27(2):195-205
pubmed: 27012384
Am J Med Genet. 1994 Oct 1;52(4):450-61
pubmed: 7747758
Neuro Oncol. 2014 Oct;16 Suppl 4:iv1-63
pubmed: 25304271
Neurosurg Focus. 2015 Apr;38(4):E10
pubmed: 25828486
Nat Genet. 2013 Mar;45(3):295-8
pubmed: 23377182
Neuro Oncol. 2021 Nov 2;23(11):1821-1834
pubmed: 34181733
Surg Neurol. 1996 Nov;46(5):458-63; discussion 463-4
pubmed: 8874546
Cancers (Basel). 2022 Aug 18;14(16):
pubmed: 36010979
Neurosurg Focus. 2003 Jun 15;14(6):e1
pubmed: 15669784
Support Care Cancer. 2022 May;30(5):3893-3902
pubmed: 35041087
J Neurosurg Spine. 2010 Jul;13(1):67-77
pubmed: 20594020
Eur Spine J. 2008 Aug;17(8):1035-41
pubmed: 18481118
Eur Spine J. 2016 Dec;25(12):4025-4032
pubmed: 26542390
Neurol Med Chir (Tokyo). 2003 Jan;43(1):12-8; discussion 19
pubmed: 12568317
Childs Nerv Syst. 2012 Jan;28(1):129-36
pubmed: 21947034
Spinal Cord. 1996 Sep;34(9):536-42
pubmed: 8883188
Neurol Med Chir (Tokyo). 2014;54(11):907-13
pubmed: 24759095
Neurosurgery. 2006 Apr;58(4):674-85; discussion 674-85
pubmed: 16575331
Nat Rev Neurol. 2013 May;9(5):257-66
pubmed: 23528542
J Neurosurg. 1989 Dec;71(6):842-5
pubmed: 2585075
Neurosurgery. 1989 Aug;25(2):153-60
pubmed: 2671779
Acta Neuropathol. 2022 Nov;144(5):1057-1059
pubmed: 36163595
Neurosurgery. 2007 Aug;61(2):226-35; discussion 235
pubmed: 17762734
Neurosurg Clin N Am. 2020 Apr;31(2):231-235
pubmed: 32147014
J Clin Neurosci. 2020 Jul;77:62-66
pubmed: 32409209
Cancers (Basel). 2022 Jun 08;14(12):
pubmed: 35740510
Neurochirurgie. 2020 Feb;66(1):41-44
pubmed: 31672597
Spine (Phila Pa 1976). 2012 May 1;37(10):E617-23
pubmed: 22146282
J Clin Oncol. 2021 Dec 1;39(34):3839-3852
pubmed: 34618539
Neurosurg Focus. 2007;23(4):E14
pubmed: 17961038
Science. 2013 Mar 1;339(6123):1077-80
pubmed: 23348505
Spine (Phila Pa 1976). 1997 Feb 15;22(4):442-51
pubmed: 9055374
Sci Rep. 2020 Jul 28;10(1):12563
pubmed: 32724039
J Neurosurg. 2003 Apr;98(3 Suppl):258-63
pubmed: 12691381
Spine (Phila Pa 1976). 2000 Mar 15;25(6):727-31
pubmed: 10752106
J Neurosurg Spine. 2019 Nov 8;:1-11
pubmed: 31703204
Lancet Neurol. 2006 Dec;5(12):1045-54
pubmed: 17110285
Technol Cancer Res Treat. 2012 Feb;11(1):27-34
pubmed: 22181328
Eur J Radiol. 2004 May;50(2):159-76
pubmed: 15081130
Neurosurg Focus. 2016 Aug;41(2):E6
pubmed: 27476848
Nat Genet. 2013 Mar;45(3):285-9
pubmed: 23334667
J Neurooncol. 2005 Nov;75(2):157-61
pubmed: 16132511
Clin Neurol Neurosurg. 2020 Nov;198:106238
pubmed: 33096449
Int J Cancer. 2022 Dec 01;151(11):1874-1888
pubmed: 35779059
Neurosurg Rev. 2020 Apr;43(2):513-523
pubmed: 30112665
J Neurooncol. 2004 Aug-Sep;69(1-3):291-318
pubmed: 15527097
Clin Neurol Neurosurg. 2009 Apr;111(3):221-6
pubmed: 19101080
J Neurosurg. 1982 Dec;57(6):804-12
pubmed: 7143063
World Neurosurg. 2020 Aug;140:e87-e96
pubmed: 32371078
Neurosurg Clin N Am. 1990 Jul;1(3):591-608
pubmed: 2136160
J Pathol. 2014 Dec;234(4):436-40
pubmed: 25143307
Surg Neurol Int. 2012;3(Suppl 3):S174-87
pubmed: 22905324
Neurosurgery. 2017 Apr 1;80(4):602-609
pubmed: 28362922
J Neuropathol Exp Neurol. 2006 May;65(5):445-54
pubmed: 16772868
Acta Neuropathol. 2022 Nov;144(5):1053-1055
pubmed: 35943573
Br J Radiol. 2018 Dec;91(1092):20180262
pubmed: 30052467
Surg Neurol. 1999 Dec;52(6):552-62
pubmed: 10660020
Neurospine. 2022 Mar;19(1):96-107
pubmed: 35378584
Technol Cancer Res Treat. 2012 Apr;11(2):133-9
pubmed: 22335407
Neuro Oncol. 2021 Aug 2;23(8):1231-1251
pubmed: 34185076
Neurosurg Focus. 2003 Jun 15;14(6):e2
pubmed: 15669787
Neurosurgery. 2013 Dec;73(6):1034-43
pubmed: 24077585
J Neurosurg. 2001 Oct;95(4):601-7
pubmed: 11596954
Neurosurg Rev. 2019 Mar;42(1):85-96
pubmed: 28900754
J Integr Neurosci. 2021 Jun 30;20(2):463-469
pubmed: 34258948
Br J Neurosurg. 1998 Dec;12(6):521-6
pubmed: 10070460
Neuro Oncol. 2019 Jan 14;21(Suppl 1):i44-i61
pubmed: 30649491
Cancers (Basel). 2021 Dec 19;13(24):
pubmed: 34944991
Spine (Phila Pa 1976). 2018 Feb 15;43(4):287-294
pubmed: 28658041
Front Oncol. 2019 Jan 09;8:651
pubmed: 30687635
Neurooncol Adv. 2020 Sep 10;2(1):vdaa113
pubmed: 33134922
J Neurosurg Spine. 2015 Sep;23(3):368-73
pubmed: 26023898
Sci Rep. 2021 Jun 2;11(1):11630
pubmed: 34079036
J Neurosurg. 1994 Jun;80(6):963-70
pubmed: 8189276
J Neurooncol. 2018 Oct;140(1):49-54
pubmed: 29926318
J Neurosurg Case Lessons. 2021 Oct 18;2(16):CASE21362
pubmed: 35855279

Auteurs

Christoph Hohenberger (C)

Department of Neurosurgery, University Medical Center Regensburg, Regensburg, Germany.
Brain Tumor Center, University Medical Center Regensburg, Regensburg, Germany.

Peter Hau (P)

Brain Tumor Center, University Medical Center Regensburg, Regensburg, Germany.
Wilhelm Sander Neuro-Oncology Unit, University Medical Center Regensburg, Regensburg, Germany.

Karl-Michael Schebesch (KM)

Department of Neurosurgery, University Medical Center Regensburg, Regensburg, Germany.
Brain Tumor Center, University Medical Center Regensburg, Regensburg, Germany.

Oliver Kölbl (O)

Department of Radiotherapy, University Medical Center Regensburg, Regensburg, Germany.
Brain Tumor Center, University Medical Center Regensburg, Regensburg, Germany.

Markus J Riemenschneider (MJ)

Department of Neuropathology, University Medical Center Regensburg, Regensburg, Germany.
Brain Tumor Center, University Medical Center Regensburg, Regensburg, Germany.

Fabian Pohl (F)

Department of Radiotherapy, University Medical Center Regensburg, Regensburg, Germany.

Martin Proeschold (M)

Department of Neurosurgery, University Medical Center Regensburg, Regensburg, Germany.
Brain Tumor Center, University Medical Center Regensburg, Regensburg, Germany.

Nils Ole Schmidt (NO)

Department of Neurosurgery, University Medical Center Regensburg, Regensburg, Germany.
Brain Tumor Center, University Medical Center Regensburg, Regensburg, Germany.

Classifications MeSH